Assessing intravascular volume status in the critically ill patient remains a challenge for intensivists, and the accuracy of such estimation based on bedside examination alone is reported to be nearly a coin toss. In this retrospective study we sought to validate a previously recommended chest radiographic vascular pedicle width (VPW) ≥70 mm for identifying cardiogenic pulmonary oedema (CPO). We additionally assessed whether novice physicians-in-training can reliably measure the VPW. The study included intensive care patients with an existing pulmonary artery catheter. Three independent raters performed measurements of VPW from chest radiographs obtained within three hours of pulmonary artery occlusion pressure measurements. In 80 patients enrolled, a VPW cut-off of ≥70 mm had a 55% sensitivity, 88% specificity, 81% positive predictive value, 69% negative predictive value and 73% accuracy for identifying patients with CPO. Receiver operating characteristic curve analysis showed an area under the curve of 0.72 (95% confidence interval 0.61 to 0.84) for VPW in discriminating CPO from non-cardiogenic pulmonary oedema. Kappa statistics for inter-rater reliability showed Kappa=0.41, 0.42 and 0.85 for each pair of the three raters. In conclusion, the previously accepted VPW cut-off of ≥70 mm is reasonably accurate in discriminating CPO from non-cardiogenic pulmonary oedema. VPW can be measured by physicians-in-training with a comparable performance to previous studies utilising expert radiologists.
Assessing and achieving optimal volume status in critically ill patients is one of the most common challenges clinicians face in the intensive care unit 1, 2 . Furthermore, physicians are less than accurate in estimating haemodynamic status based on clinical assessment alone, especially in patients with acute heart disease 3, 4 . The cumulative evidence suggests that the pulmonary artery (PA) catheter is a diagnostic rather than a therapeutic tool 5 . At the same time, continued debate regarding its usefulness has led to development of non-invasive or minimally invasive devices 6, 7 . Nonetheless, the PA catheter continues to be a reference standard against which other haemodynamic monitoring technologies are tested.
Portable chest radiography has long been the most commonly used, non-invasive tool to evaluate for the presence of pulmonary oedema [8] [9] [10] . With respect to critical illness, clinicians often make patient care decisions based on a best estimate of whether pulmonary oedema seen on a chest radiograph reflects cardiogenic or non-cardiogenic origin. Such estimates may also lead to incorrect determination of a patient's volume status. To overcome this limitation and use of the chest radiograph as a haemodynamic monitoring tool, Milne et al described the vascular pedicle width (VPW) as a method for assessing the aetiology of pulmonary oedema 11 . The VPW is a measurement of the mediastinal silhouette of the great vessels on the chest radiograph. Since its initial description, various cut-off values for differentiating cardiogenic from non-cardiogenic pulmonary oedema have been studied 12 .
In this study we planned to validate the recommended VPW cut-off value of ≥70 mm as an indicator of cardiogenic pulmonary oedema (CPO) and VPW <70 mm as an indicator of non-cardiogenic pulmonary oedema (NCPO). We also hypothesised that the VPW can be accurately and reliably measured by self-trained, novice, non-radiology physicians-intraining. 
MATERIALS AND METHODS

Study design and setting
This study was a retrospective analysis of chest radiographs and haemodynamic variables obtained in critically ill patients at an 815-bed, tertiary care university hospital. Electronic medical records of patients in all intensive care units from October 2009 through to March 2011 were reviewed. The study was approved by our Institutional Review Board, with waiver of informed consent and authorisation (approval number: 5-11-0124).
The primary outcome was the classification function of the VPW cut-off of 70 mm in identifying CPO and NCPO on chest radiographs. Pulmonary artery occlusion pressure (PAOP) obtained from PA catheterisation was used as the reference standard. We a priori defined CPO as PAOP ≥18 mmHg, while NCPO was defined as PAOP <18 mmHg 13 . The secondary outcome was the reliability of VPW measurements when performed by multiple novice raters after completion of self-training materials.
Patient selection
Eligible patients were included if they: 1) were 18 years or older, 2) had a PAOP measurement recorded in the electronic medical record, 3) had a chest radiograph obtained within three hours of the PAOP measurement, and 4) had evidence of pulmonary oedema on the chest radiograph. In order to compare our results with previous studies, we selected the three-hour interval between chest radiograph and PAOP measurement, similar to Rice et al 14 . Patients were excluded if there was known or suspected mediastinal pathology that may contribute a mass effect, such as aortic dissection, lymphadenopathy, pneumothorax and malignancy.
The Department of Decision Support Services at our institution provided a list of patients with PAOP measurement(s) recorded in the medical chart over the study period. Two members of the study team reviewed the patient list and enrolled patients based on the above enrolment criteria.
Data collection
Digital chest radiographs were obtained with the GE AMX portable X-Ray machine (GE Healthcare, Fairfield, CT, USA) using standard 14×17 cm solid media plates. The digital images were viewed using IMPAX ® software (Agfa HealthCare Corp., Greenville, SC, USA). Clinical data were obtained from the medical chart, which included demographics, haemodynamic measurements, reason(s) for PA catheterisation, laboratory results, treatments and resource consumption. PA catheter calibration was performed per standard practice at the time of haemodynamic measurements.
The VPW was measured and radiographic findings recorded independently by three members of the study team (Rater 1, Rater 2 and Rater 3), each of whom was blinded to the PAOP measurement and other clinical information at the time of review. All raters were physicians-in-training. None of the raters had postgraduate/specialist training in radiology or VPW measurement. Prior to the study, each rater was supplied with two chapters from definitive radiology textbooks, which provided instructional information on evaluating chest radiographs with pulmonary oedema and measurement of VPW 15, 16 . Each rater was required to complete the self-training materials prior to performing VPW measurements for the study purpose.
The VPW was measured by applying the original method described by Milne et al to a digital chest radiograph using the electronic ruler provided in the IMPAX ® software package 11, 17 . The technique involves measuring horizontally across from the point at which the superior vena cava and right mainstem bronchus cross to the intersection, with a vertical line drawn from the junction of the left subclavian artery and aortic arch ( Figure 1 ).
Statistical analysis
The study population was divided into those with NCPO and those with CPO (PAOP <18 mmHg and PAOP ≥18 mmHg, respectively). Descriptive statistics In this study patient, VPW=74 mm, with pulmonary artery occlusion pressure=30 mmHg measured within three hours of the chest radiograph. PAOP=pulmonary artery occlusion pressure, VPW=vascular pedicle width. We defined the mean VPW as the average of the VPW values obtained by the three independent raters. The mean VPW was then used to determine the classification function of VPW and to perform comparisons with PAOP. A 2×2 contingency table was formulated to categorise mean VPW (≥70 mm and <70 mm) against PAOP (≥18 mmHg and <18 mmHg). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of mean VPW ≥70 mm in determining CPO were then calculated. A scatter plot was generated and a correlation analysis was performed by Pearson's method to determine the correlation coefficient between mean VPW and PAOP. Receiver operating characteristic (ROC) curve analysis was performed to determine the ability of mean VPW to discriminate CPO from NCPO, with the area under the ROC curve calculated using non-parametric tests (trapezoidal rule) as described by Hanley and McNeil 18, 19 .
Finally, reliability analysis was performed for VPW measurements obtained by the three independent raters using absolute and percentage difference, as well as Pearson's correlation analysis on a continuous scale. Kappa analysis was performed to determine inter-rater reliability of VPW measurements. PASW 18.0 (SPSS Inc., Chicago, IL, USA) was used to perform all statistical analyses. A P value <0.05 was determined as significant.
RESULTS
Eighty patients were enrolled in the study with age 59±14 years, 26.2% female and 56.3% Caucasian. Forty-two patients had NCPO (PAOP <18 mmHg) compared to 38 patients with CPO (PAOP ≥18 mmHg). There was no difference in age, gender, race, intensive care unit length-of-stay, hospital length-of-stay, mechanical ventilation, reason for PA catheterisation and therapies in patients with NCPO compared to CPO (Table 1 ). Compared to NCPO, patients with CPO had significantly higher positive end-expiratory pressure, pulmonary artery pressure, central venous pressure, PAOP and mean VPW (all P <0.01). Patients with CPO had higher haemoglobin (P=0.01) and lower pH (P <0.01) compared to patients with NCPO.
Classification function of VPW measurements
In all study patients, PAOP was 17.9±8.4 mmHg and mean VPW was 65.4±9.7 mm. Patients with NCPO had a mean VPW of 62.1±7.5 mm, whereas patients with CPO had a mean VPW of 69.2±10.7 mm (P <0.01, Table 1 ). The 2×2 contingency table classifying patients based on the mean VPW cut-off of ≥70 mm showed this cut-off had a 55% sensitivity, 88% specificity, 81% positive predictive value, 69% negative predictive value and 73% accuracy for identifying patients with CPO (or PAOP ≥18 mmHg) ( Table 2) .
A scatter plot of PAOP versus mean VPW demonstrated a significant correlation between VPW and PAOP (r=0.36, P <0.01) ( Figure 2 ). ROC curve analysis showed an area under the curve of 0.72 (95% confidence interval 0.61 to 0.84) for mean VPW in discriminating CPO from NCPO (Figure 3) .
Reliability of VPW measurements
The absolute and percent difference in VPW measurements among the three raters are illustrated in Table 3 . Pearson correlation analysis showed r=0.54 to 0.86 (all P <0.01). Kappa statistics for inter-rater reliability showed κ=0.41, 0.42 and 0.85 for each pair of the three raters, respectively (all P <0.01).
Qualitative assessment of chest radiographic features was independently performed by each of the three raters ( Table 4 ). The cardiothoracic ratio was defined as the transverse diameter of the heart divided by the width of the thoracic cage and was visually estimated as ≤ or >50%. The absence or presence of pleural effusion, septal lines, peribronchial cuffing, air bronchograms and pulmonary oedema was subjectively noted by each rater. There was variability among the three raters, such that none of the subjective radiographic features was consistently different between NCPO and CPO. However, VPW was significantly different between NCPO and CPO as measured by all three raters (P <0.01, <0.01 and 0.01, respectively).
DISCUSSION
The evaluation of intravascular volume status remains a common challenge in critically ill patients. Additionally, when pulmonary oedema is observed, differentiation of cardiogenic from non-cardiogenic aetiology is of paramount importance given the potentially divergent treatment strategies. The struggle is, in part, due to a lack of a single 'perfect' diagnostic tool. The previously regarded 'gold standard' monitor to which new haemodynamic monitoring modalities are compared is the PA catheter. However, given the well-known evidence against routine PA catheterisation and the decrease in its use since the landmark study by Connors et al, the evaluation of a practical bedside method in assessing volume status becomes prudent 20, 21 . Other than positive end-expiratory pressure, haemoglobin and pH, we observed no clinical difference between patients with NCPO versus CPO, except for the invasively obtained haemodynamic data from PA catheterisation. This observation was striking and further supports a practical and non-invasive means in distinguishing the haemodynamic profile between these two groups of patients. We verified that the previously accepted VPW cut-off of ≥70 mm has a 73% accuracy in discriminating CPO (defined as PAOP ≥18 mmHg) from NCPO (PAOP <18 mmHg), which was comparable to the results reported in previous studies when VPW was assessed by expert radiologists.
Measurements of the VPW and its use in distinguishing CPO from NCPO were initially described by Milne et al almost 30 years ago 11, 17 . They examined VPW in normal volunteers and different types of pulmonary oedema, showing a normal range of 43 to 53 mm for VPW in the upright (erect) position. VPW increased by an average of 20% in the supine position. Furthermore, rotation to the left decreased VPW and to the right increased its measurement, whereas inspiration or expiration caused little change. The mean VPW ≥70 mm has 55% sensitivity, 88% specificity, 81% positive predictive value, 69% negative predictive value and 73% accuracy for identifying patients with PAOP ≥18 mmHg or cardiogenic pulmonary oedema. VPW=vascular pedicle width, PAOP=pulmonary artery occlusion pressure. Over a five-day study period that included VPW measurements on day zero, one, three and five, VPW was significantly decreased by 5.2 mm in the treated patients. Changes in VPW correlated significantly with changes in volume status, weight, central venous pressure and PAOP.
To our knowledge, there are five previous studies examining VPW as a determinant of volume status compared to PAOP as the reference standard, three of which were performed by the same group of investigators 14, [25] [26] [27] [28] . By defining CPO as PAOP ≥18 mmHg in these studies, the ability of VPW to discriminate CPO from NCPO showed an area under the ROC curve ranging from 0.69 to 0.85. There was significant correlation between VPW and PAOP, r=0.41 to 0.68. All these studies utilised expert radiologists to determine VPW measurements. Using novice, non-radiologists, we were able to show similar discrimination and correlation of VPW to PAOP.
Among previous studies, Ely et al performed the largest prospective study, enrolling 100 patients who had a pulmonary artery catheter in place and were scheduled to have a chest radiograph on the morning of enrolment 26 . PAOP measurements were obtained within one hour of the digital chest radiographs. The study showed that clinicians' bedside assessments in distinguishing CPO from NCPO had an accuracy of 48%, and the overall accuracy of subjective reading of the chest radiographs by experienced radiologists was 56%. In relation to our results, the key finding in their study was that VPW measured by radiologists from portable, supine chest radiographs had the best cut-off of ≥70 mm in differentiating PAOP ≥18 from PAOP <18 mmHg, with an accuracy of 67%. They also noted that the addition of cardiothoracic ratio (CTR) measurements improved the ability to determine volume status from a chest radiograph, such that a combined VPW ≥70 mm and CTR >0.55 had an accuracy of 70%. The likelihood ratio of determining volume status using VPW and CTR by experienced radiologists was significantly higher than using subjective chest radiograph interpretation with or without clinical data. Their study, for the first time, addressed the use of digitally acquired radiographs. However, the images were printed and measurements conducted by three experienced chest radiologists. In our study, we evaluated digital radiographs using the IMPAX ® software, including its various adjustment tools to correct for potentially poor quality images and highly accurate digital rulers to obtain VPW measurements. We showed that self-trained, nonradiologist physicians-in-training had an accuracy of 73% in measuring VPW to differentiate CPO from NCPO.
Despite convincing data and at least two review articles outlining an algorithm to include VPW into routine practice, the technique has neither been widely adopted nor consistently taught to physiciansin-training 29, 30 . We believe this is, in part, due to a perception that prior studies lack generalisability, given their design of incorporating expert radiologists to determine VPW measurements. In our study, we a priori accepted the VPW cut-off ≥70 mm and PAOP ≥18 mmHg in determining CPO. We provided simple self-training materials to physicians-in-training that can be completed in less than one hour. A previous study had included two inexperienced raters (among five raters), requiring a half-day training session from an experienced intensivist 14 . For most non-intensivists, physicians-in-training or even practising intensivists unfamiliar with measuring VPW, there may be no access to an expert chest radiologist at their institution. We included patients with or without positive pressure ventilation. We did not differentiate between supine or upright chest radiographs and did not consider patient position in our VPW measurements. Thus, we believe our approach was practical and reflects the daily critical care practice. Our results suggest that VPW measurements can be easily learned and applied with acceptable accuracy and reliability by non-radiologists.
Our study had several limitations. The retrospective study design prevented real-time clinical data from being incorporated in classifying patients as CPO versus NCPO. However, we used the accepted standard of PAOP ≥18 mmHg in defining CPO, consistent with previous studies 14, [25] [26] [27] [28] . When polling our group of intensivists, we received a similar consensus as Ely et al, who found that 92% (35 of 38) of their colleagues at two separate hospitals used a PAOP of 18 mmHg as a clinical threshold for cardiogenic volume overload 26 . We also intentionally did not include an expert radiologist rater and aimed to only examine the ability of novice raters to measure VPW with PAOP as the reference standard in determining CPO versus NCPO. Although the accuracy of the non-expert raters reported in this study is similar to previous studies including experts to measure VPW, we did not make a direct comparison between the two groups and therefore cannot confirm whether the non-expert raters are comparable to expert raters in assessing VPW in critically ill patients.
Our study included high-risk patients who had a PA catheter in place. Since this study was retrospective, based on available clinical data, we did not have an objective measure of severity of illness. However, it is clear that our patient population is high-risk, with 81.3% on mechanical ventilation and 58.8% receiving vasopressor at the time of PAOP measurement. We observed that patients with CPO had statistically higher positive end-expiratory pressure levels than those patients with NCPO. While we did not account for the effect of positive pressure ventilation, Milne et al showed that inspiration and expiration caused little change in VPW measurements 17 . From their unpublished observations, Miller and Ely also noted that VPW measurements were relatively consistent between spontaneous and positive-pressure breaths 30 . Thus we believe that VPW measurements would also be applicable in the less severe, non-intubated patients with pulmonary oedema. We did not examine the additional value of CTR combined with VPW in differentiating CPO from NCPO, as did previous authors 25, 26 . Our study aim was to evaluate the accuracy and reliability of the VPW itself as a measure of volume status, such that our results may have implications for its use as a functional haemodynamic variable 31 . Martin et al showed that VPW changed over time, whereas CTR did not change significantly over a five-day treatment course of diuretic and albumin in patients with acute lung injury 24 . Our level of accuracy using VPW alone was similar to or better than previous studies combining VPW and CTR 25, 26 . Thus, we believe that VPW alone is sufficient and that future studies may further confirm its use in haemodynamic monitoring.
In conclusion, our study showed that VPW can be easily measured by novice clinicians to discern CPO from NCPO with acceptable reliability. Since its introduction in the 1980s and a limited body of evidence regarding its use as a determinant of volume status, VPW has not been commonly taught to physicians-intraining. However, digital chest radiographs are now virtually ubiquitous in daily patient care, together with readily available software for image optimisation and analysis. Thus, the VPW on the chest radiograph may be a viable tool to incorporate in routine critical care. When added with other clinical factors, it may further avoid the need for invasive haemodynamic monitoring in those patients with pulmonary oedema.
